Physician

Lince K Varughese, M.D.

According to 2025 Medicare claims, Lince Varughese, M.D. (NPI: 1699193276) practices family practice in the Dallas-Plano-Irving, TX market, with the plurality of this provider's patient population coming from Rockwall, TX. This provider's primary affiliated billing organization is RESTORE AESTHETICS, PLLC (NPI: 1922849728; TIN: 931569650) and primary practice location at 75032-9998.

Varughese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 119 traditional Medicare patients, billed 1,126 HCPCS/CPT codes, and received $345,172 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 1,034 prescription claims across 203 beneficiaries totaling $38,342 in drug costs, led by Jardiance (Empagliflozin). DME data shows 36 claims. Open Payments data shows 20 records totaling $688. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,095 to $345,172. Similarly, Part D prescription costs have risen steadily, from $4,920 to $38,342. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	36	207	$12,095
2019	194	1,027	$57,414
2020	207	961	$47,554
2021	183	1,924	$91,329
2022	296	2,754	$138,318
2023	277	2,173	$112,046
2024	119	1,126	$345,172

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	69	$4,920
2016	33	237	$15,315
2017	22	167	$7,894
2018	29	50	$5,878
2019	41	119	$15,413
2020	75	141	$12,316
2021	116	347	$17,622
2022	151	375	$22,209
2023	177	496	$46,504
2024	203	1,034	$38,342

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$262
2020	N/R	22	$2,965
2021	86	201	$25,654
2022	115	185	$29,815
2023	95	116	$9,431
2024	N/R	36	$2,566

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	52	52	$58
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	64	115	$42
11042	Removal of skin and tissue, 20.0 sq cm or less	92	457	$42
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	26	27	$23

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	12	360	$7,764
Linezolid	Linezolid	23	207	$2,073
Gentamicin Sulfate	Gentamicin Sulfate	42	1,134	$1,585
Potassium Chloride	Potassium Chloride	60	1,624	$837
Levothyroxine Sodium	Levothyroxine Sodium	72	2,225	$766

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	N	N/R	11	$1,652
A6209	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	N	N/R	11	$856
A6216	Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing	N	N/R	14	$59

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$688	Smith+Nephew, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lince K. Varughese, M.D.?

Tedicare shows public-source Medicare data for Lince K. Varughese, M.D. (NPI 1699193276), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lince K. Varughese, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lince K. Varughese, M.D.?

Lince K. Varughese, M.D. is linked to RESTORE AESTHETICS, PLLC (billing NPI 1922849728) in the available physician profile data.

Does Lince K. Varughese, M.D. have Open Payments data?

Lince K. Varughese, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.